Remove topic it
article thumbnail

Leo scores again in hand eczema with its JAK inhibitor cream

Fierce Pharma

It’s been four years since Japan Tobacco snagged approval in its home country for its topical JAK inhibitor delgoci | It’s been four years since Japan Tobacco snagged approval in its home country for its topical JAK inhibitor delgocitinib to treat atopic dermatitis.

Pharma 206
article thumbnail

With global expansion planned, Krystal lays out blockbuster ambitions for topical gene therapy

Fierce Pharma

Not even one year after becoming a commercial biotech, Krystal Biotech has blockbuster dreams for its flagship product. | In its first six months of commercial availability, Krystal's topical gene therapy Vyjuvek raked in more than $50 million.

260
260
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Incyte's JAK cream Opzelura proves its worth in treating hidradenitis suppurativa in midstage study

Fierce Pharma

After a pair of approvals in recent years and as its sales continue to climb, Incyte's topical JAK inhibitor Opzelura is adding to its clinical case with trial results that demonstrate its benefits | The company presented positive data from a phase 2 study in mild-to-moderate hidradenitis suppurativa at the American Academy of Dermatology's (..)

Sales 225
article thumbnail

Stagnant sales for Dermavant's Vtama cast doubt on its blockbuster potential

Fierce Pharma

As a result, Leerink Partners has slashed its sales projections for the nonsteroidal topical treatment. In the market, however, Vtama is struggling to catch on.

Sales 188
article thumbnail

ABCs of Data Normalization for B2B Marketers

It’s not a far stretch to suggest that the topic isn’t exactly what gets marketers excited in their day-to-day workflow. Data normalization. However, if lead generation, reporting, and measuring ROI is important to your marketing team, then data normalization matters - a lot.

article thumbnail

Krystal's topical gene therapy gains steam, prompting analyst group to boost sales projection

Fierce Pharma

At the start of its first-ever conference call to present its quarterly numbers, Krystal Biotech CEO Krish Krishnan was quick to point out that the company’s positive earnings for the third quarter | Krystal Biotech's launch of Vyjuvek, the world's first topical gene therapy, has been so promising that analysts with Evercore ISI increased (..)

Sales 254
article thumbnail

Pharma marketing: Getting personalized with Fingerpaint Group

Fierce Pharma

Fingerpaint Group’s Paul Hagopian sits down with Fierce Pharma to discuss what has become a hotly contested topic. Marketers operating in every sector are seeking ways to offer personalized, high-quality experiences to their target audiences. | How much influence will AI exert over pharma marketing?

Marketing 210
article thumbnail

ABM Success Recipe: Mastering the Crawl, Walk, Run Approach

Key topics will include: Getting started: the "crawl" phase of ABM and its boundaries Unlocking the potential of the "run" phase and using the right strategy for scaling your efforts The essential components of an effective ABM tech stack within each stage Real-world insights from NetSPI's ABM journey with MarketingOS